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ABSTRACT 
Objective: Here, we report the extracellular synthesis of silver nanoparticles (AgNPs) using the cell-free extract of fungal isolate Aspergillus flavus 
and evaluation its inhibitory activity against bacterial pathogens.  
Methods: Synthesized AgNPs was characterized via high throughput instrumentation such as UV–Visible spectrophotometer (UV-Vis) and Fourier 
transform infrared spectroscopy, High-resolution transmission electron microscopy (HRTEM), X-ray Diffraction (XRD) and Energy dispersive X-ray 
spectroscopy (EDAX).  
Results: Formation of yellowish brown colour clearly indicates the synthesis of AgNPs which produces a SPR peak at 420 nm. Active protein 
metabolites present in the cell-free extract plays a crucial role in reduction and stabilization of AgNPs. It was clearly observed that synthesized 
AgNPs were faced-centered cubic crystalline in nature with the mean size of 22±11 nm. Further, synthesized AgNPs capped with protein moieties 
exhibits excellent inhibitory activity against tested bacterial pathogens. 
Conclusion: In this study, we have isolated the fungal strain A. flavus from the infected larvae of D. eucharis from the soil. The active metabolites of 
isolated A. flavus have been successfully used as an eco-friendly reducing agent to generate AgNPs and synthesized particles can be potentially 
developed as a drug candidature for antimicrobial therapy.  
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INTRODUCTION  
In recent times, nanotechnology is being considered as an 
impressive technology through which various nanosystems with 
improved size, distribution, and morphology have been developed 
for advanced biomedical applications. Especially, nanostructures of 
noble metals such as silver, platinum, gold and palladium have 
received huge attention due to their specific physical, chemical, 
optical, electronic, magnetic and mechanical properties [1].  
Generally, materials at nanoscale level have been fabricated 
routinely either “top-down or “bottom-up” approaches. Most of the 
physical and chemical methods of nanoparticles synthesis were too 
expensive and involved with the utilization of toxic chemicals which 
is hazardous to the environment and its associated life forms. Now, a 
new innovative route using different biological entities such as 
plants, microbes, yeast, and actinomycetes have been developed as 
an alternative eco-friendly approach [2]. 
There are several routes to reach metal nanoformulations like 
sonochemical, thermal decomposition, microwave irradiation 
(electrochemical, ablation, chemical reduction, and recently green 
synthesis. Unfortunately, many of the nanoparticle synthesis or 
production methodologies are persists with the use hazardous 
chemicals, low material conversions, high energy requirements and 
difficulty in purifications on the major contaminants [3]. Therefore, 
there is a growing need to develop environmental friendly processes 
for nanoparticle synthesis without disturbing the environment and 
its associated life forms. 
In general, microorganisms were widely exploited for various 
commercial biotechnological processes such as bioleaching and 
bioremediation to extract metals from the ores. These unicellular 
organisms hold the tendency to produce inorganic metal 
nanoparticles either intra-or extracellularly with unique 
physiochemical properties. It was recognized that generation of 
nanoparticles occurs after the conversion metal ions into an element 
in the presence of microbial enzymes either inside the cell or on the 
surface of the cell [4].  
Interestingly, in the case of biological synthesis, the interaction 
between nanomaterials with active metabolites provides 
functionalized hybrid nanomaterials. A number of fungal species 
such as Cochliobolus lunatus, Fusarium oxysporum, Aspergillus 
fumigate, Aspergillus niger, Aspergillus clavatus, Epicoccum nigrum, 
Amylomyces rouxii [5-11] have been screened for their 
nanobiotechnological potential with noble metals such as silver 
and gold.  
Moreover, development of microbial resistance, the prospectus to 
manage the public health crisis has worsened drastically. Although 
several new antibiotics have been developed in the last few 
decades, none of them have been found with improved activity 
against multidrug-resistant pathogenic organisms. Therefore, it is 
imperative to design better therapeutic strategies, including new 
antibiotics [12]. Hence, the present study was focused on a native 
fungal strain A. flavus isolated from infected cadavers of butterfly 
Delias eucharis larvae, and assessed for the synthesis of AgNPs for 
antimicrobial potentials.  
MATERIALS AND METHODS 
Materials 
Silver nitrate (AgNO3) and other chemicals were purchased from 
Himedia Laboratories, Mumbai, India. The infected cadavers of 
butterfly (Delias eucharis) larvae were collected from Bharathidasan 
university campus, Tiruchirappalli, Tamilnadu. 
Methods 
Isolation and identification of A. flavus  
A native fungal strain was isolated from the infected cadavers of 
butterfly (Delias eucharis) larvae. Initially, strain was plated on 
martin rose bengal agar media and plates were incubated at 28 °C 
for 4 d. Individual colonies were picked and further purified by using 
potato dextrose agar (PDA) media. Morphological and microscopic 
observation (such as colour, texture of mycelia, spore formation 
pattern, etc.,) were made for recovered strain; further genomic DNA 
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was isolated by CTAB method [13] according to the stranded 
protocol. The internal transcribed spacer (ITS) amplified primer 
ITS1 and ITS4 with 5´-TCCGTAGGTGAACCTGCGG-3´ and 5´-
TCCTCCGCTTATTGATATGC-3´ sequences respectively and PCR 
amplified product were sequenced. Finally, the resulting sequence 
was entered into BLAST algorithm of National Centre of Biological 
Information (NCBI) database for closely related phylogenetic 
sequences. The phylogenetic tree was constructed through 
maximum likelihood method in Mega 6.0 software. 
Synthesis of AgNPs  
A. flavus was maintained on PDA slants for 28 °C with regular sub-
culture of fresh media. The stock culture of A. flavus was inoculated 
in 500 ml SDA (Sabouraud Dextrose Agar) and incubated in 28±1 °C 
for 1week. Then, the biomass was separated by whatman filter 
paper No.1. The reaction mixture for the synthesis of AgNPs was 
prepared by blending 10 ml of the fungal extracts to 90 ml of 1 mmol 
AgNO3 solution in a 250 ml conical flask and incubated at 29 °C for 
reduction. 
Characterization of AgNPs 
The myco-synthesized AgNPs was initially confirmed by measuring 
the absorbance spectra using UV-Vis spectroscopy in the wavelength 
range between300-700 nm in JASCO V-650 spectrophotometer. 
Synthesized AgNPs was stored at room temperature for 90 d to 
check its stability. FTIR-Spectroscopic analysis was carried out to 
find the possible bio-reducing agent present in the fungus (A. flavus) 
responsible for reduction and stabilization of AgNPs. For that, the 
sample was mixed with KBr powder and pelletized after drying the 
spectra were recorded using Perkin Elmer make model spectrum 
RX1 (wavelength range between 4000 cm-1 and 400 cm-1). X-ray 
diffraction measurements of AgNPs were carried on XRD 600, 
Shimadzu, Japan instruments operating at a voltage of 40Kv and 
current of 30mA with CuK radiation. To perform TEM analysis, a 
drop of aqueous solution containing the AgNPs sampled onto carbon 
coated copper grids and dried under an infrared lamp. TEM 
observations were made with TECNAI-10 operated at an 
accelerating voltage at 100kv. In addition, to check the purity and 
presence of metal (Ag)in the sample (AgNPs) EDAX analysis was 
executed.  
Screening of antimicrobial activity 
The antibacterial activity of AgNPs was evaluated by agar well 
diffusion method [14] against human pathogenic bacteria such as E. 
coli, B. subtilis, E. faecalis, S. flexneri, K. pnemoniae, S. epidermis and P. 
mirabilis in the Mueller-Hinton agar media (MHA) with different 
concentration of AgNPs (25, 50 and 100 μg/ml). Streptomycin 
sulphate was used as a control. After 24 h incubation at 37 °C, a zone 
of inhibition (ZOI) was measured and the diameters of ZOI were 
measured using a meter ruler. The assay was done in triplicate, and 
the results were given in mean±SD. 
RESULTS AND DISCUSSION  
Isolation and molecular identification of A. flavus  
In general, fungi are beneficial than other biological agents for 
AgNPs synthesis as demeanour great metal uptake and lenience and 
well binding ability [16].  
 
 
Fig. 1: a. Morphology of isolated fungi A. flavus b. Phylogenetic 
analysis of fungal isolated from the infected cadaver. The 
phylogenetic tree was constructed based on ITS-1 and ITS-4 
sequences using the maximum parsimony method in MEGA ver. 
5.2. The percentage of replicate trees in which the associated 
taxa clustered together in the bootstrap test (1,000 replicates) 
is shown next to the branch 
 
Additionally, myco-synthesized AgNPs have good monodispersed, 
controlled size, and shape with hydrophilic nature [17]. In this study, A. 
flavus was isolated from the infected cadaver of D. eucharis butterfly. We 
have used the conidia and mycelia morphology to for preliminary 
confirmation (fig. 1a) and further it was confirmed by rDNA sequence 
analysis. The sequence was then aligned with the CLUSTAL W program 
and later the aligned sequence was subjected to phylogenetic tree 
construction based on the neighbour joining method encompassing with 
1000 bootstrap replications (fig. 1b). In the phylogenetic tree, the species 
were clustered into their respective genus clade. This revealed that the 
isolated fungal sequences showed 98% homology with A. flavus.  
Synthesis of AgNPs 
The fungal extracellular filtrate was added with 1 m mol AgNO3 
solution, after 24-72 h incubation the appearance of brown colour 
has strongly confirmed the synthesis of AgNPs in the reaction 
mixture (fig. 2a). The appearance of the dark brown colour was due 
to the excitation of surface plasmonic resonance (SPR), which is a 
characteristic feature of AgNPs [18]. 
  
 
Fig. 2: a. Development of yellowish brown color indicates the generation of AgNPs b. Synthesized AgNPs produces intense absorbance 
spectra 420 nm in UV-Visible spectroscopy 
Characterization of AgNPs 
It was generally recognized that UV–Vis spectroscopy could be 
used to study the size and shape of nanoparticles in suspensions 
[19]. The SPR of AgNPs were characteristics an absorbance 
spectrum in the visible area of electromagnetic radiation at 420 
nm which is recorded in UV–Visible spectrophotometer (fig. 2b). 
FTIR analysis shows the transmittance at 3464 cm-1, 2077 cm-1, 
1637 cm-1 and 679 cm-1which indicates the functional group of the 
fungal compounds which involves in the reduction of AgNPs (fig. 
3a). The transmittance attributes O-H stretch, C=C bond and C-H 
which reveals that the water soluble heterocyclic components and 
certain proteins existing in the filtrate actively involved in the 
reduction of silver nitrate. Similar phenomenon has been reported 
earlier [20], where it was clealy mentioned that these active 
protein biomolecules present in the culture filterate of the act as 
reducing and capping agent. XRD analysis was carried out to 
determine the crystalline nature of myco-synthesized AgNPs. X-ray 
diffractogram intensities were interpreted with JCPDS which 
shows the diffraction planes at (111), (200), (220) and (311) 
depicts that myco synthesized AgNPs were cubic crystalline in 
nature (fig. 3b). Our result highly matches with many earlier 
reports which shows XRD 2θ values that corresponding to the face 
cantered cubic structure of AgNPs [21]. 
 
 
Fig. 3: a. FTIR spectra of myco synthesized AgNPs shows the presence of protein moieties as capping agent b. XRD analysis of AgNPs 
 
TEM images shows the precise size, shape and morphology of myco-
synthesized AgNPs (fig. 4a). It displays spherical AgNPs with the size 
range between with an average size of.,the particles were well 
dispersed, and no direct contact was noticed mainly due to the 
presence of the capping agent. EDAX analysis shows a strong metal 
peak for Ag at 3 keV presence of a copper metal peak is due to grid 
used for the analysis (fig. 4b).  
 
 
Fig. 4: a. TEM-Analysis of myco synthesized AgNPs; b. EDAX 
analysis myco synthesized AgNPs 
 
In the fig. 4b, the elemental analysis of AgNPs revealed the highest 
proportion of silver which suggests the present of Ag as the major 
ingredient element followed by carbon and oxygen metal elements.  
Antibacterial activity 
Smaller particles with a more surface range have greater 
antibacterial effects compared to larger particles [22]. The 
antimicrobial efficacy of myco synthesized AgNPs was assessed 
against various pathogens. Synthesized AgNPs showed potential 
antibacterial activity against all tested pathogens like E. coli, B. 
subtilis, S. flexneri, E. faecalis,K. pnemoniae, S. epidermis and P. 
mirabilis. It was observed that increased concentration of AgNPs (75 
μg/ml) inhibits the bacterial growth progressively (fig. 5a and b).  
 
Fig. 5: a. Antibacterial activity of AgNPs against human 
pathogens A-K. pnemoniae, B-P. mirabilis, C-S. typhi, D-S. 
flexneri, E-B. subtilis, E-E. faecalis, F-E. coli Concentrations: 1-25 
µg/ml; 2-50 µg/ml; 3-75μg/ml; 4-antibiotics. b. Antimicrobial 
activity of AgNPs against bacterial pathogens. The test was 
performed in triplicate and the results were given in mean±SD 
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This eminent antibacterial activity of AgNPs is owed to its expert 
surface property [19]. The highest zone of inhibition was observed 
against P. mirabilis and S. flexneri at the concentration of 100µg/ml. 
Lowest zone of inhibition against the B. subtilis and S. epidermis (7 
mm). When concentration is increased the activity of AgNPs was 
also getting improved. Furthermore, Ag is acidic in nature, requiring 
the trend to respond with bases,when AgNPs react with DNA 
containing sulfur and phosphorous groups it eradicates the DNA or 
failure of respiratory chain reaction [23]. 
CONCLUSION 
In the present study, a native fungal strain was successfully isolated 
from a novel habitat D. eucaris infected cadavers. The isolated fungal 
strain was identified as A. flavus based on its morphological and 
molecular characterization. The culture filterate of A. flavus was 
efficaciously used as straight bio-reductant to convert Ag+into Ag °. 
Myco-synthesised AgNPs were characterized by UV–vis 
spectroscopy, FTIR, XRD and HRTEM which visibly portrays the 
formation of highly stable face-centered cubic AgNPs. Further, the 
myco-synthesized AgNPs was very promising and showed excellent 
antibacterial activity against human bacterial pathogens. Based on 
the results it was proposed that myco-synthesised AgNPs can be 
developed as a potential nanomaterial for biomedical applications. 
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